Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study
Abstract Background Chronic widespread pain conditions (CWP) such as the pain associated with fibromyalgia syndrome (FMS) are significant health problems with unclear aetiology. Although CWP and FMS can alter both central and peripheral pain mechanisms, there are no validated markers for such altera...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-06-01
|
Series: | Lipids in Health and Disease |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12944-017-0505-7 |
id |
doaj-3b52bd6bdab246f683a4a52e30d08f82 |
---|---|
record_format |
Article |
spelling |
doaj-3b52bd6bdab246f683a4a52e30d08f822020-11-24T21:35:02ZengBMCLipids in Health and Disease1476-511X2017-06-011611910.1186/s12944-017-0505-7Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control studyNiclas Stensson0Bijar Ghafouri1Björn Gerdle2Nazdar Ghafouri3Pain and Rehabilitation Centre, Department of Medical and Health Sciences, Linköping UniversityPain and Rehabilitation Centre, Department of Medical and Health Sciences, Linköping UniversityPain and Rehabilitation Centre, Department of Medical and Health Sciences, Linköping UniversityPain and Rehabilitation Centre, Department of Medical and Health Sciences, Linköping UniversityAbstract Background Chronic widespread pain conditions (CWP) such as the pain associated with fibromyalgia syndrome (FMS) are significant health problems with unclear aetiology. Although CWP and FMS can alter both central and peripheral pain mechanisms, there are no validated markers for such alterations. Pro- and anti-inflammatory components of the immune system such as cytokines and endogenous lipid mediators could serve as systemic markers of alterations in chronic pain. Lipid mediators associated with anti-inflammatory qualities – e.g., oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and stearoylethanolamide (SEA) – belong to N-acylethanolamines (NAEs). Previous studies have concluded that these lipid mediators may modulate pain and inflammation via the activation of peroxisome proliferator activating receptors (PPARs) and the activation of PPARs may regulate gene transcriptional factors that control the expression of distinct cytokines. Methods This study investigates NAEs and cytokines in 17 women with CWP and 21 healthy controls. Plasma levels of the anti-inflammatory lipids OEA, PEA, and SEA, the pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and IL-8, and the anti-inflammatory cytokine IL-10 were investigated. T-test of independent samples was used for group comparisons. Bivariate correlation analyses, and multivariate regression analysis were performed between lipids, cytokines, and pain intensity of the participants. Results Significantly higher levels of OEA and PEA in plasma were found in CWP. No alterations in the levels of cytokines existed and no correlations between levels of lipids and cytokines were found. Conclusions We conclude that altered levels of OEA and PEA might indicate the presence of systemic inflammation in CWP. In addition, we believe our findings contribute to the understanding of the biochemical mechanisms involved in chronic musculoskeletal pain.http://link.springer.com/article/10.1186/s12944-017-0505-7Chronic widespread painInflammationN-acylethanolaminesPalmitoylethanolamideOleoylethanolamideCytokines |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Niclas Stensson Bijar Ghafouri Björn Gerdle Nazdar Ghafouri |
spellingShingle |
Niclas Stensson Bijar Ghafouri Björn Gerdle Nazdar Ghafouri Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study Lipids in Health and Disease Chronic widespread pain Inflammation N-acylethanolamines Palmitoylethanolamide Oleoylethanolamide Cytokines |
author_facet |
Niclas Stensson Bijar Ghafouri Björn Gerdle Nazdar Ghafouri |
author_sort |
Niclas Stensson |
title |
Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study |
title_short |
Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study |
title_full |
Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study |
title_fullStr |
Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study |
title_full_unstemmed |
Alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study |
title_sort |
alterations of anti-inflammatory lipids in plasma from women with chronic widespread pain - a case control study |
publisher |
BMC |
series |
Lipids in Health and Disease |
issn |
1476-511X |
publishDate |
2017-06-01 |
description |
Abstract Background Chronic widespread pain conditions (CWP) such as the pain associated with fibromyalgia syndrome (FMS) are significant health problems with unclear aetiology. Although CWP and FMS can alter both central and peripheral pain mechanisms, there are no validated markers for such alterations. Pro- and anti-inflammatory components of the immune system such as cytokines and endogenous lipid mediators could serve as systemic markers of alterations in chronic pain. Lipid mediators associated with anti-inflammatory qualities – e.g., oleoylethanolamide (OEA), palmitoylethanolamide (PEA), and stearoylethanolamide (SEA) – belong to N-acylethanolamines (NAEs). Previous studies have concluded that these lipid mediators may modulate pain and inflammation via the activation of peroxisome proliferator activating receptors (PPARs) and the activation of PPARs may regulate gene transcriptional factors that control the expression of distinct cytokines. Methods This study investigates NAEs and cytokines in 17 women with CWP and 21 healthy controls. Plasma levels of the anti-inflammatory lipids OEA, PEA, and SEA, the pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and IL-8, and the anti-inflammatory cytokine IL-10 were investigated. T-test of independent samples was used for group comparisons. Bivariate correlation analyses, and multivariate regression analysis were performed between lipids, cytokines, and pain intensity of the participants. Results Significantly higher levels of OEA and PEA in plasma were found in CWP. No alterations in the levels of cytokines existed and no correlations between levels of lipids and cytokines were found. Conclusions We conclude that altered levels of OEA and PEA might indicate the presence of systemic inflammation in CWP. In addition, we believe our findings contribute to the understanding of the biochemical mechanisms involved in chronic musculoskeletal pain. |
topic |
Chronic widespread pain Inflammation N-acylethanolamines Palmitoylethanolamide Oleoylethanolamide Cytokines |
url |
http://link.springer.com/article/10.1186/s12944-017-0505-7 |
work_keys_str_mv |
AT niclasstensson alterationsofantiinflammatorylipidsinplasmafromwomenwithchronicwidespreadpainacasecontrolstudy AT bijarghafouri alterationsofantiinflammatorylipidsinplasmafromwomenwithchronicwidespreadpainacasecontrolstudy AT bjorngerdle alterationsofantiinflammatorylipidsinplasmafromwomenwithchronicwidespreadpainacasecontrolstudy AT nazdarghafouri alterationsofantiinflammatorylipidsinplasmafromwomenwithchronicwidespreadpainacasecontrolstudy |
_version_ |
1725946915108945920 |